Bohen Sean — SEC Form 4 filings

SEC reporting owner CIK 1831218. 5 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-05 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Olema Pharmaceuticals, Inc. (OLMA)PRESIDENT AND CEO, Director53 legs · 109,502 sh · $986,3656

Form 4 filings — Bohen Sean

FiledFormIssuerReported transactionsSource
2026-02-044Olema Pharmaceuticals, Inc. (OLMA)Grant/award (A): 850,000 (derivative) @ $0 · Grant/award (A): 275,000 (derivative) @ $0EDGAR
2025-12-304Olema Pharmaceuticals, Inc. (OLMA)Gift (G): 8,500 @ $0EDGAR
2025-03-034Olema Pharmaceuticals, Inc. (OLMA)Grant/award (A): 650,000 (derivative) @ $0EDGAR
2024-12-114Olema Pharmaceuticals, Inc. (OLMA)Grant/award (A): 204,750 @ $0 · Sale (S): 52,328 @ $9.37 · Sale (S): 55,907 @ $8.66 · Sale (S): 1,267 @ $9.39EDGAR
2024-02-054Olema Pharmaceuticals, Inc. (OLMA)Grant/award (A): 621,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1831218 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →